On January 20, 2025, Donald Trump announced that, during his second term as president, the United States would enter a new ...
EQT Life Sciences has co-led a €51 million Series B financing in Exciva to support a Phase 2 clinical trial of Deraphan, a novel therapy for agitation associated with Alzheimer’s disease. The round, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback